Efficacy of sitagliptin added on to intensive insulin therapy in type 2 diabetic patients

Bengur Taskiran, Guven Baris Cansu
  • Endocrine Abstracts, May 2015, Bioscientifica
  • DOI: 10.1530/endoabs.37.ep400
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.1530/endoabs.37.ep400

The following have contributed to this page: MD Güven Barış Cansu